An association between a high concentration of IL-18 in the serum of COPD patients and a decline in lung function parameters allows IL-18 levels to be used as a marker of the degree of impaired airway obstruction in COPD [4]. The gene discussed is IL18; the disease is chronic obstructive pulmonary disease.